Contact OTC Dynamics on Twitter OTC Dynamics on Facebook
Custom solutions for retail traders

Tag: Harrow Health Inc. News

$HROW Harrow Closes Acquisition of U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE® and Will Begin Receiving Net Profit Payments for Acquired Products
on January 23, 2023 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
on January 5, 2023 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
on January 5, 2023 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
HROW
Source:
Read more

$HROW Melt Pharmaceuticals’ MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study
on December 21, 2022 News and Tags: , , , with 0 comments
Time:
7:21 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Secures Capital to Close Recently Announced Acquisition
on December 16, 2022 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Secures Capital to Close Recently Announced Acquisition
on December 16, 2022 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE®
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:30 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Prices $25 Million Offering
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:31 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:32 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE®
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:30 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Prices $25 Million Offering
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:31 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
on December 14, 2022 News and Tags: , , , with 0 comments
Time:
4:32 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow and iOR Partners Expand National Product Supply Agreement
on November 30, 2022 News and Tags: , , , with 0 comments
Time:
6:00 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Announces Third Quarter 2022 Financial Results
on November 14, 2022 News and Tags: , , , with 0 comments
Time:
2:05 PM
Symbol:
HROW
Source:
Read more

$HROW Harrow Launches Atropine.com
on November 10, 2022 News and Tags: , , , with 0 comments
Time:
6:00 AM
Symbol:
HROW
Source:
Read more

$HROW Harrow Launches Atropine.com
on November 10, 2022 News and Tags: , , , with 0 comments
Time:
6:00 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Sells Non-Ophthalmic Compounding Business
on October 5, 2022 News and Tags: , , , with 0 comments
Time:
5:35 PM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation
on September 29, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
on September 27, 2022 News and Tags: , , , with 0 comments
Time:
1:50 PM
Symbol:
HROW
Source:
Business Wire
Read more

$HROW Harrow Health Announces Second Quarter 2022 Financial Results
on August 9, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
HROW
Source:
Business Wire
Read more